Member Info for crumbs

A storm but a possible perfect storm?... modi1 comes along at a time when it is also an even more needed than previously potential treatment as many of its targeted patients are at record high numbers due to lock down under diagnosis and treatment...... come on team Scancell

BOJO I think this is the first bit of that kind of PR scancell have ever done infact Im sure it is lol... not sure about the soundtrack (probably Chippers input that )) but yes I like it a lot!... We are investing in a proper Biotech Oxford-based.... the genius of Lindy made physical and like her we hope sustainable.... potential is MASSIVE and yes we are talking many many £billions of mcap...of course, all hinges on the data but that is now coming

Data data.... at least these Oxford labs will give scancell the ability to go through the bloods themselves etc.....So ...positive Covidity data and I think we will be well on our way considering that is two platforms ..... moditope is coming... It certainly looks like Lindy is very confident in moditope.

Ruck indeed and really it shows us how the company we began with really was 'just' a University spin-out... now it is a 'proper' Biotech and I think far more investable I like the idea of it being a sustainable company too... I'm looking forwards to this next stage of the journey :)

Good observation... not sure if it means anything though could be to do with Zakari or indeed one representing Notts based Scancell the other Oxford I dunno.... intrigued about the expansion of Avidimabs capabilities.... improve any vaccine? .... might have to get emailing Lindy

Brilliant!
https://www.youtube.com/watch?v=BS1KVWNclTI

And what an AGM presentation..... the fruits of decent investment from solid investors.... if left to haribos of the world they would indeed be cardboard labs :) onwatds!

Loch I wonder who that would be lol

No it is Zzzzzzzzzakari Therapeutics :)

I don't expect to see that scenario ever (it does not look like their form) much more likely IMHO is they fund the production of data (already happening) to multiple product inflexion point partnership deal/s (next step) then with a healthy mcap and prospective future a NASDAQ IPO when redmile likely begin to divest at a whopping profit leaving a Lindy led mid-tier bio and indeed potential pharma in a healthy sustainable state..... at what point pi jump in and out it is entirely up to them :)

Mr Piedmont said it will be cheaper to ship spodumene from Ghana to their plant than from Canada ... Ewoyya could end up being multiple times bigger than it already is with a mine life well in excess of 10 years it is one the greenest Lithium projects in the world and the mine ought to be producing in 2023, not in 5 years time... plus it is now listed on the US market whos investors may well have a different persepective than AIM pi's... the correct pr and boom lol a dangerous game to be out I'd say but this is AIM :)

ALL will get a pr boost plus Vinnie said they will be mining commercial Lithium in 2023.... no way there will not be a significant rerate before then... The resource will be possibly substantially upgraded soon too... think there will be plenty of ALL action and am happy to nibble away at these lows... Ricca a bonus that previously was giving no value

Well the Covid vaccine market is projected to be worth more than $120 billion by next year
The MaB market :'The market is projected to grow from USD 178.50 billion in 2021 to USD 451.89 billion in 2028'
As for Moditope and indeed the new next gen SCIbs it is all about the numbers of targets and amount of potential patients.... with moditope it would make its own market as the patients whom would hopefully most benefit currently have no treatment beyond palative available.... price on that... dunno but lets just compare with Checkpoit inhibitor market :'checkpoint inhibitors market was valued at $10,566 million in 2017, and is projected to reach $56,530 million by 2025' of that most is one product keytruda $23 billion or thereabouts...... moditope is like having a potential pipeline of keytrudas ....
So potential value lol.... 'A lot' maybe the best way to describe it as Scancells pipeline is made up of multiple potential game-changer products in all the above markets ......

Well of course the anticipation of what biscuits may or may not be on offer deserves intensifying hysteria! Let it be Rich Teas seeing as I won't be there to dunk em :)

Of course, best of all would be if Scancell videoed the whole event though that probably won't happen so if anyone can record it...fantastic ,Botski used to be the guy but I dunno if he is still here or going? Possibly the timelines ground him down in the end which is understandable ....I reckon it will mostly be a Lindy and Sally show which is the best kind

I guess you mean trading days C7 :) Though I won't be able to make it to AGM and personally would have prefered a virtual one ... just looked at the venue! V posh! Much as I imagine your pad mate :) .... As ever all feedback will be most welcome and hopefully loads of productive questions ... which I think will be more the case this time round.

Only a couple of years ago the Covid vaccine market of over $120 billion a year did not exist well it does now and that is why scancells full mcap potential is not possible to predict beyond it could be massive and run into the many many billions making any who enjoy the ride to that happy place a very decent return :) if you are out at 50p or a quid or indeed a tenner lol..... first things first data/deals then the 'sustainable business' plan will show itself .....

This place is full of party poopers :) Hopefully AGM will raise the spirits

Ruck, you should know the party doesn't start till 8! :)

Sure it is another cancer vaccine so all good and wish it well we know the moditope approach is a quite unique one and if proves itself in the clinic will find its backers and market It is good to see this new vax recruiting and I would expect the same with modi1 it should not be another SCIB1 combo saga and will recruit patients quite fast I expect .... I think with SCIB1 combo it may well be all about in a certain timeframe if it manages to recruit it will continue but if not and if other juicy news ( Covidity/Modi1 etc) comes in it will be dropped in an 'AIM market-sensitive way' as we all know AIM would just love an RNS to say trial abandoned :)) better to do it on a high so it is not of sp consequence

Morning Ivy, I have to say I don't know anything about that treatment till you posted but on a google search, I found the news about it and this quote from the article says it all really as this is indeed the realm of moditope .... it is a market that does not exist yet as hopefully the patients it successfully treats are currently untreatable.... hopefully this new treatment does indeed work and moditope too....Also would expect we will see such coverage once dosing begins like you say soon we hope

'Earlier this month, Sezgin Hick, a 61-year-old mother of two from Teddington, south-west London, was given the first of three fortnightly jabs to shrink her tumours, which had spread from her ovary into her lymph nodes and abdomen.

This was despite almost eight years of chemotherapy and immunotherapy treatments. She is the first of 36 critically ill patients who will be recruited into the vaccine trial, which experts say could eventually include people with a wide range of cancer types.

Ms Hick, a former intensive care nurse, who was diagnosed with ovarian cancer in 2012, has been told the new vaccine is now the only treatment available to her as all others have failed to work.'
https://toysmatrix.com/cancer-vaccine-breakthrough-terminally-ill-patients-in-new-trial-could-change-landscape/